SIRNAOMICS-B: PROXY FORM
SIRNAOMICS-B: ANNOUNCEMENT IN RELATION TO PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION
SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES COMPLETION OF IND-ENABLINGSTUDIES OF SAFETY AND EFFICACY FOR STP125G WITHNHP MODELS, TARGETING APOC3 FOR TREATMENT OFCARDIOVASCULAR DISEASES
SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES INTERIM RESULTS FOR SUCCESSFULCOMPLETION OF THE SECOND COHORT OF PHASE I CLINICALSTUDY OF GALNAC-BASED RNAi THERAPEUTIC STP122G FORANTICOAGULANT THERAPEUTICS
SIRNAOMICS-B: INSIDE INFORMATION - POTENTIAL LOSS IN RELATION TO FUND SUBSCRIPTIONSANDESTABLISHMENT OF INVESTIGATION COMMITTEE
SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
SIRNAOMICS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
SIRNAOMICS-B: CHANGES IN COMPOSITION OF BOARD COMMITTEES ANDCOMPLIANCE WITH THE LISTING RULES
SIRNAOMICS-B: CLARIFICATION ANNOUNCEMENT
SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES COMPLETION OFSTP707 PHASE I CLINICAL STUDY WITHSTRONG SAFETY PROFILE AND STABLE DISEASE ACTIVITYFOR THE TREATMENT OF PANCREATIC CANCER PATIENTS
SIRNAOMICS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
SIRNAOMICS-B: RESIGNATION OF CHIEF MEDICAL OFFICERAND CHIEF FINANCIAL OFFICER
SIRNAOMICS-B: PROXY FORM
SIRNAOMICS-B: ANNOUNCEMENT IN RELATION TOPROPOSED AMENDMENTS TO THE MEMORANDUMAND ARTICLES OF ASSOCIATION
SIRNAOMICS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
SIRNAOMICS-B: RESIGNATION OF CHIEF STRATEGY OFFICER
SIRNAOMICS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
SIRNAOMICS-B: APPOINTMENT OF EXECUTIVE DIRECTOR
SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
No Data